PHILADELPHIA, July 30, 2020 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two virtual conferences in August 2020.
- LifeSci Partners Private Company Virtual Summer Symposium
Tuesday, August 4, 2020 at 3:30 p.m. EDT - Wedbush PacGrow Healthcare Virtual Conference
Wednesday, August 12, 2020 at 12:35 p.m. EDT
About CARISMA Therapeutics Inc.
CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.
For more information, please visit www.carismatx.com
Media Contact:
Christina Khoury-Folkens
612-806-0757
[email protected]
SOURCE CARISMA Therapeutics Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article